Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Bifidobacterium animalis subsp. lactis BB-12 and Improved Immune Function

Research synthesisVery low evidenceMixed effect size4 studies · 4 beneficial · 0 neutral · 0 harmful

Across 4 review studies, all 4 reported beneficial effects of Bifidobacterium animalis subsp. lactis BB-12 on immune function, with effect sizes ranging from small to large (predominantly small to moderate). The most robust evidence comes from one high-quality review citing increased resistance to common respiratory infections. No consistent dose range was reported, and study durations were not specified.

Caveats: Evidence base is small (only 4 studies) — conclusions should be considered preliminary. All included studies are reviews, not original clinical trials, and none reported statistical significance or provided extractable dose, duration, or sample size data. Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed).

Generated Jun 11, 2026
4 of 4 papers
Back to top